A sense of the bigger picture: A qualitative analysis of follow-up interviews with people with bipolar disorder who self-reported psilocybin use
- Author: mycolabadmin
- 12/14/2022
- View Source
Summary
Background
Bipolar disorder affects approximately 2.4% of the global population and is among the leading causes of disability worldwide. Current pharmacological treatments for bipolar depression are inadequate with inconsistent efficacy and significant side effects. Emerging evidence suggests psilocybin is a promising treatment for unipolar depression, yet clinical trials universally exclude individuals with bipolar disorder diagnoses.
Objective
This study aimed to understand subjective impacts of psilocybin use on bipolar disorder symptoms through follow-up qualitative interviews with survey respondents. The research sought to deepen understanding of preliminary survey results and elucidate specific contextual factors associated with adverse reactions in naturalistic settings.
Results
Conclusion
- Published in:PLoS One,
- Study Type:Qualitative Study,
- Source: PMID: 36516137, DOI: 10.1371/journal.pone.0279073